HGHarald Gross

Harald Gross

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Harald Gross has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Anja Krick

    Department of Botany, University of Khartoum, Khartoum, Sudan, Institute for Pharmaceutical Biology, University of Bonn, 53115 Bonn, Germany, Institute of Experimental Oncology, Oncotest GmbH, 79108 Freiburg, Germany, Centre for Biomolecular Drug Research (BMWZ), Leibniz Universität Hannover, Schneiderberg 1B, 30167 Hannover, Germany, Department of Medicinal Chemistry, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany, and Institute for Molecular Biology and Department of...

    2 shared publications
  • Armin Maier

    Department of Botany, University of Khartoum, Khartoum, Sudan, Institute for Pharmaceutical Biology, University of Bonn, 53115 Bonn, Germany, Institute of Experimental Oncology, Oncotest GmbH, 79108 Freiburg, Germany, Centre for Biomolecular Drug Research (BMWZ), Leibniz Universität Hannover, Schneiderberg 1B, 30167 Hannover, Germany, Department of Medicinal Chemistry, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany, and Institute for Molecular Biology and Department of...

    2 shared publications
  • Gabriele Maria König

    Institute of Pharmaceutical Biology, University of Bonn, Nussallee 6, 53115 Bonn, Germany

    2 shared publications
  • Gerhard Kelter

    Department of Botany, University of Khartoum, Khartoum, Sudan, Institute for Pharmaceutical Biology, University of Bonn, 53115 Bonn, Germany, Institute of Experimental Oncology, Oncotest GmbH, 79108 Freiburg, Germany, Centre for Biomolecular Drug Research (BMWZ), Leibniz Universität Hannover, Schneiderberg 1B, 30167 Hannover, Germany, Department of Medicinal Chemistry, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany, and Institute for Molecular Biology and Department of...

    2 shared publications
  • Heinz-Herbert Fiebig

    Department of Botany, University of Khartoum, Khartoum, Sudan, Institute for Pharmaceutical Biology, University of Bonn, 53115 Bonn, Germany, Institute of Experimental Oncology, Oncotest GmbH, 79108 Freiburg, Germany, Centre for Biomolecular Drug Research (BMWZ), Leibniz Universität Hannover, Schneiderberg 1B, 30167 Hannover, Germany, Department of Medicinal Chemistry, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany, and Institute for Molecular Biology and Department of...

    2 shared publications
  • Ietidal E. Mohamed

    Department of Botany, University of Khartoum, Khartoum, Sudan

    2 shared publications

Latest Publications

  • Mode of Action of Epoxyphomalins A and B and Characterization of Related Metabolites from the Marine-Derived Fungus Paraconiothyrium sp.

    by Ietidal E. Mohamed, Stefan Kehraus, Anja Krick, Gabriele M. König, Gerhard Kelter, Armin Maier, Heinz-Herbert Fiebig, Markus Kalesse, Nisar P. Malek, Harald Gross

    Epoxyphomalins A (1) and B (2) are highly potent cytotoxic fungal metabolites. During the course of purifying larger quantities of 1 and 2 from Paraconiothyrium sp. fermentation extracts, three new epoxyphomalins (3−5) were isolated and characterized, showing modifications to the oxidation pattern of the cyclohexene moiety or of C-9 of the decalin system. IC50 values for cytotoxicity against a panel of 36 human tumor cell lines were determined for all new compounds. Compound 4 was found to be cytotoxic particularly toward prostate PC3M (IC50 = 0.72 μM) and bladder BXF 1218 L (IC50 = 1.43 μM) cancer cell lines. In addition, inhibition of chymotrypsin-, caspase-, and trypsin-like activity of purified 20S proteasomes was determined for epoxyphomalins A (1) and B (2). The results indicate that compounds 1 and 2 exert their cytotoxic effect through potent inhibition of the 20S proteasome.


  • Genome-Driven Investigation of Compatible Solute Biosynthesis Pathways ofPseudomonas syringaepv. syringae and Their Contribution to Water Stress Tolerance

    by Matthias Kurz, Adrien Y. Burch, Britta Seip, Steven E. Lindow, Harald Gross

    The foliar pathogenPseudomonas syringaepv. syringae exhibits an exceptional ability to survive on asymptomatic plants as an epiphyte. Intermittent wetting events on plants lead to osmotic and matric stresses which must be tolerated for survival as an epiphyte. In this study, we have applied bioinformatic, genetic, and biochemical approaches to address water stress tolerance inP. syringaepv. syringae strain B728a, for which a complete genome sequence is available.P. syringaepv. syringae B728a is able to produce the compatible solutes betaine, ectoine,N-acetylglutaminylglutamine amide (NAGGN), and trehalose. Analysis of osmolyte profiles ofP. syringaepv. syringae B728a under a variety ofin vitroandin plantaconditions reveals that the osmolytes differentially contribute to water stress tolerance in this species and that they interact at the level of transcription to yield a hierarchy of expression. While the interruption of a putative gene cluster coding for NAGGN biosynthesis provided the first experimental evidence of the NAGGN biosynthetic pathway, application of this knockout strain and also agfpreporter gene fusion strain demonstrated the small contribution of NAGGN to cell survival and desiccation tolerance ofP. syringaepv. syringae B728a underin plantaconditions. Additionally, detailed investigation ofectC, an orphan of the ectoine cluster (lacking theectAandectBhomologs), revealed its functionality and that ectoine production could be detected in NaCl-amended cultures ofP. syringaepv. syringae B728a to which sterilized leaves ofSyringa vulgarishad been added.


  • Open Access

    Pregna-1,4,20-trien-3-one, a cytotoxic marine steroid from the marine soft coralNephtheasp.

    by Maria B. Tabot, Gregor Schnakenburg, Harald Gross

    The title compound, C(21)H(28)O, was isolated from the cytotoxic lipid extract of the Fidjian soft coral Nephthea sp. The steroid showed inhibitory activity to human colon adenocarcinoma SW480 cells (IC(50) = 2.5 µg ml(-1)). The mol-ecular structure indicates that the A ring is almost planar (r.m.s. deviation = 0.032 Å), the B and C rings adopt chair conformations and the five-membered D ring is a half-chair. The B/C and C/D ring junctions are trans-fused.

  • Epoxyphomalin A and B, Prenylated Polyketides with Potent Cytotoxicity from the Marine-Derived Fungus Phoma sp.

    by Ietidal E. Mohamed, Harald Gross, Alexander Pontius, Stefan Kehraus, Anja Krick, Gerhard Kelter, Armin Maier, Heinz-Herbert Fiebig, Gabriele M. König

    Chemical investigation of a strain of the marine-derived fungus Phoma sp. has led to the discovery of epoxyphomalin A (1) and B (2), two new prenylated polyketides with unusual structural features. Epoxyphomalin A (1) showed superior cytotoxicity at nanomolar concentrations toward 12 of a panel of 36 human tumor cell lines. In COMPARE analyses, the observed cytotoxic selectivity pattern of 1 did not correlate with those of reference anticancer agents with known mechanisms of action.


  • Top Cited Papers

    Genomics of secondary metabolite production by Pseudomonas spp.

    by Harald Gross, Joyce E. Loper

    Covering: up to June 2009 Pseudomonas is a diverse genus of Gammaproteobacteria with more than 60 species exhibiting varied life styles in a wide range of environments, including soil, water, plant surfaces, and animals. They are well known for their ubiquity in the natural world, capacity to utilize a striking variety of organic compounds as energy sources, resistance to a wide range of medically- and agriculturally-important antimicrobial compounds, and production of a remarkable array of secondary metabolites. Here, we provide an overview of the astonishing metabolic capacity of the Pseudomonads, summarize the knowledge of secondary metabolite biosynthesis in this group of organisms, and highlight the biological significance of these compounds to the diverse life styles exhibited by Pseudomonas spp. A consistent theme throughout this discussion is the central role of genomics in natural product discovery, characterization of metabolic gene clusters and patterns of their inheritance, and illuminaton of new aspects of Pseudomonas biology.


    • 1 March 2009
      • Vol. 12  (2) , 207-19

    Genomic mining--a concept for the discovery of new bioactive natural products.

    by Harald Gross

    Natural products continue to represent an excellent source for lead structures for drug discovery. However, new concepts are required to increase the probability of finding new bioactive structures. The post-genomic world has revealed that the traditional culture-based, bioassay-guided strategies used to discover natural products have only provided access to a small fraction of the biosynthetic capacity encoded in genomes. It has become apparent that the majority of biosynthetic pathways are expressed not at all, or scarcely, under laboratory conditions, or the products of these pathways have been overlooked. Genomic mining seeks to address both of these issues and thus to exploit the hidden potential of biosynthetic pathways. This fascinating, interdisciplinary research field began to form with the turn of the millennium, and, in establishing itself, has opened the door to a new era in natural products drug discovery.


  • Open Access

    Three New Spongian Diterpenes from the Fijian Marine Sponge Spongia sp

    by Harald Gross, Anthony D. Wright, Uwe Reinscheid, Gabriele M. König

    Chemical investigation of the marine sponge Spongia sp., collected from the Fiji Islands resulted in the isolation of three new furanoditerpenoids 1-3, along with the known compounds epispongiatriol (4) and 17,19-dihydroxyspongia-13(16),14-dien-2,3-dione (5) While 1 is a new spongian diterpene with a modified oxidation pattern, compounds 2 and 3 represent two new ring A-contracted spongians, displaying a novel and unprecedented nor-spongian carbon skeleton. Despite their labile nature the structures could be established through a combined strategy including complete analysis of spectroscopic data (NMR, MS), molecular modeling and quantum-mechanical calculations.


  • Isolation and Identification of Rhizoxin Analogs from Pseudomonas fluorescens Pf-5 by Using a Genomic Mining Strategy

    by Joyce E. Loper, Marcella D. Henkels, Brenda T. Shaffer, Frederick A. Valeriote, Harald Gross

    The products synthesized from a hybrid polyketide synthase/nonribosomal peptide synthetase gene cluster in the genome of Pseudomonas fluorescens Pf-5 were identified using a genomics-guided strategy involving insertional mutagenesis and subsequent metabolite profiling. Five analogs of rhizoxin, a 16-member macrolide with antifungal, phytotoxic, and antitumor activities, were produced by Pf-5, but not by a mutant with an insertion in the gene cluster. The five rhizoxin analogs, one of which had not been described previously, were differentially toxic to two agriculturally important plant pathogens, Botrytis cinerea and Phytophthora ramorum . The rhizoxin analogs also caused swelling of rice roots, a symptom characteristic of rhizoxin itself, but were less toxic to pea and cucumber roots. Of the rhizoxin analogs produced by Pf-5, the predominant compound, WF-1360 F, and the newly described compound 22 Z -WF-1360 F were most toxic against the two plant pathogens and three plant species. These rhizoxin analogs were tested against a panel of human cancer lines, and they exhibited potent but nonselective cytotoxicity. This study highlights the value of the genomic sequence of the soil bacterium P. fluorescens Pf-5 in providing leads for the discovery of novel metabolites with significant biological properties.


  • Strategies to unravel the function of orphan biosynthesis pathways: recent examples and future prospects

    by Harald Gross

    The recent increase and availability of whole genome sequences have revised our view of the metabolic capabilities of microorganisms. From these data, a large number of orphan biosynthesis pathways have been identified by bio-informatics. Orphan biosynthetic pathways are gene clusters for which the encoded natural product is unknown. It is worthy to note that the number of orphan pathways coding for putative natural products outnumbers by far the number of currently known metabolites for a given organism. Whilst Streptomyces coelicolor was known to produce only 4 secondary metabolites, the genome analysis revealed 18 additional orphan biosynthetic pathways. It is intriguing to note that this is not a particular case because analysis of other microbial genomes originating from myxobacteria, cyanobacteria and filamentous fungi showed the presence of a comparable or even larger number of orphan pathways. The discovery of these numerous pathways represents a treasure trove, which is likely to grow exponentially in the future, uncovering many novel and possibly bio-active compounds. The few natural products that have been correlated with their orphan pathway are merely the tip of the iceberg, whilst plenty of metabolites await discovery. The recent strategies and methods to access these promising hidden natural products are discussed in this review.